- Previous Close
172.00 - Open
172.00 - Bid 162.10 x 40000
- Ask 176.42 x 40000
- Day's Range
172.00 - 172.50 - 52 Week Range
159.16 - 237.38 - Volume
115 - Avg. Volume
51 - Market Cap (intraday)
11.021B - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
45.67 - EPS (TTM)
3.53 - Earnings Date Feb 13, 2025
- Forward Dividend & Yield 2.70 (1.67%)
- Ex-Dividend Date Mar 20, 2025
- 1y Target Est
--
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
www.cochlear.comRecent News: CHEOF
View MorePerformance Overview: CHEOF
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHEOF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHEOF
View MoreValuation Measures
Market Cap
11.02B
Enterprise Value
10.93B
Trailing P/E
45.73
Forward P/E
37.17
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.34
Price/Book (mrq)
9.05
Enterprise Value/Revenue
7.53
Enterprise Value/EBITDA
29.11
Financial Highlights
Profitability and Income Statement
Profit Margin
16.05%
Return on Assets (ttm)
12.29%
Return on Equity (ttm)
20.31%
Revenue (ttm)
2.31B
Net Income Avi to Common (ttm)
370.5M
Diluted EPS (ttm)
3.53
Balance Sheet and Cash Flow
Total Cash (mrq)
383.1M
Total Debt/Equity (mrq)
13.20%
Levered Free Cash Flow (ttm)
254.24M